Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma. - Chohan KL; Saul EE; Davis RE; Hagemeister F; Steiner R; Fayad L; Ahmed S; Rodriguez A; Iyer SP; Nair R; Vega F; Chihara D; et al. (Blood cancer journal, 2026)